Zobrazeno 1 - 10
of 42
pro vyhledávání: '"Inga Buchmann"'
Autor:
Kirsten Lindner, Daniel Binte, Jens Hoeppner, Ulrich F. Wellner, Dominik M. Schulte, Sebastian M. Schmid, Kim Luley, Inga Buchmann, Lars Tharun, Tobias Keck, Judith Gebauer, Birte Kulemann
Publikováno v:
Current Oncology, Vol 28, Iss 4, Pp 3071-3080 (2021)
Surgery remains the only curative treatment of pancreatic neuroendocrine neoplasms (pNEN). Here, we report the outcome after surgery for non-functional pNEN at a European Neuroendocrine Tumor Society (ENETS) center in Germany between 2000 and 2019; c
Externí odkaz:
https://doaj.org/article/883b0d62de7c4b1da1fbc300b6dd8ada
Autor:
Jens Hoeppner, Birte Kulemann, Lars Tharun, Kirsten Lindner, Tobias Keck, Judith Gebauer, Dominik M. Schulte, Daniel Binte, Inga Buchmann, Ulrich F. Wellner, Kim Barbara Luley, Sebastian M. Schmid
Publikováno v:
Current Oncology
Volume 28
Issue 4
Pages 268-3080
Current Oncology, Vol 28, Iss 268, Pp 3071-3080 (2021)
Volume 28
Issue 4
Pages 268-3080
Current Oncology, Vol 28, Iss 268, Pp 3071-3080 (2021)
Surgery remains the only curative treatment of pancreatic neuroendocrine neoplasms (pNEN). Here, we report the outcome after surgery for non-functional pNEN at a European Neuroendocrine Tumor Society (ENETS) center in Germany between 2000 and 2019
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::164690f6507c8bc68c49a4d1e086de78
https://doi.org/10.3390/curroncol28040268
https://doi.org/10.3390/curroncol28040268
Autor:
Karel Pacak, Joan Nambuba, Electron Kebebew, Clara C. Chen, Samira M. Sadowski, Peter Herscovitch, Inga Buchmann, Corina Millo, David Taïeb, Antonio Tito Fojo, Karen T. Adams, Ingo Janssen, Nicholas J. Patronas
Publikováno v:
Journal of Nuclear Medicine. 57:186-191
Pheochromocytomas/paragangliomas overexpress somatostatin receptors, and recent studies have already shown excellent results in the localization of sympathetic succinate dehydrogenase complex, subunit B, mutation-related metastatic pheochromocytomas/
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f5792bd643bb6613a7dda92c4a056153
https://doi.org/10.2967/jnumed.115.161018
https://doi.org/10.2967/jnumed.115.161018
Autor:
Inga Buchmann, Jens Konitzer
Publikováno v:
Der Klinikarzt. 41:470-475
Die Radioiodtherapie mit 131-Iodid (131I) beim differenzierten Schilddrusenkarzinom dient in erster Linie der Ablation von postoperativ verbliebenem Schilddrusenrestgewebe zur Optimierung der Nachsorge, lediglich beim papillaren Mikrokarzinom wird in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e1a3cb51d5fefd5f12bb56adf1d03f9d
https://doi.org/10.1055/s-0032-1330948
https://doi.org/10.1055/s-0032-1330948
Publikováno v:
European Journal of Nuclear Medicine and Molecular Imaging. 36:484-498
High-dose radio-/chemotherapy in the context of autologous and allogeneic haematopoietic stem cell transplantation is a double-edged sword. The requirement for dose intensification is linked to an increase in toxicity to noninvolved organs. Particula
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9a2d060fb1f8ac12ee950ba8de0cbdb9
https://doi.org/10.1007/s00259-008-0996-6
https://doi.org/10.1007/s00259-008-0996-6
Publikováno v:
Nuklearmedizin. 48:30-36
Ziel: Die Serumspiegel von Tumornekrosefaktor-α (TNF-α) steigen durch aggressive myeloablative Konditionierungstherapien mit Hochdosis-Chemotherapie und total body irradiation (TBI) vor allogener Stammzelltransplantation. Dies ist mit einer erhohte
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f9ab1831f093927d93c5f5db4fa2e58a
https://doi.org/10.3413/nukmed-0200
https://doi.org/10.3413/nukmed-0200
Publikováno v:
Zeitschrift für Gastroenterologie. 46:367-375
Positron emission Tomography (PET) with 2-[(18)F]-fluoro-2-deoxy-d-glucose (FDG) is a functional imaging technique with increasing value in special diagnostic fields of gastrointestinal tumours. In the initial staging of esophageal and gastric cancer
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::63da3682d836fe98f58d1126fbd303d6
https://doi.org/10.1055/s-2007-963637
https://doi.org/10.1055/s-2007-963637
Autor:
Inga Buchmann, Simone Hoffner, Uwe Haberkorn, Sebastian Aulmann, Karen Riedmüller, Ulrich Mack
Publikováno v:
Cancer Biotherapy and Radiopharmaceuticals. 22:779-789
Breast carcinomas express the Na(+)/I() symporter and may-albeit not a routine procedure-be imaged with (123)iodide ((123)I) and (99m)technetium-pertechnetate ((99m)TcO(4)(-)) scintigraphy. The aim of our prospective study was the comparison of (99m)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2a348748ac1c050030b4e894c41e33ca
https://doi.org/10.1089/cbr.2007.358
https://doi.org/10.1089/cbr.2007.358
Publikováno v:
Protein & Peptide Letters. 14:273-279
With the advances in genomics, molecular biology including gene vector technologies today's molecular imaging modalities have strongly been improved. The major progress is based on peptide and antibody targeting vectors. When labeled with beta(-)-emi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::daf827df3c89e3f80cf03d4ddd065d1c
https://doi.org/10.2174/092986607780090874
https://doi.org/10.2174/092986607780090874
Autor:
Peter Herscovitch, Ingo Janssen, Clara C. Chen, Karel Pacak, Inga Buchmann, Antonio Tito Fojo, Karen T. Adams, David Taïeb, Electron Kebebew, Corina Millo, Katherine I. Wolf, Alexander Ling, Frank I. Lin
Publikováno v:
European journal of nuclear medicine and molecular imaging. 43(10)
Pheochromocytomas/paragangliomas (PPGLs) and their metastases are tumors that predominantly express somatostatin receptor 2 (SSR2). 68Ga-DOTA(0)-Tyr(3)-octreotate (68Ga-DOTATATE) is a PET radiopharmaceutical with both high and selective affinity for
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::099fcf295745f0801e1f8d17d1309534
https://pubmed.ncbi.nlm.nih.gov/26996779
https://pubmed.ncbi.nlm.nih.gov/26996779